Follow-up of a randomized, double-blind, controlled clinical study on reducing postoperative recurrence and metastasis of colorectal cancer with Quxie Capsule

Clinical randomized controlled trial of Quxie Capsule against postoperative recurrence and metastasis of colorectal cancer

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039015

Enrollment

Unknown

Registered

2020-10-13

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

The treatment group:Conventional treatment add Quxie capsule

The control group:Quxie capsule was not added to conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with colorectal cancer diagnosed by pathology or cytology after radical resection. (2) The surgical stage is stage A, B or C. (3) Aged 18-75 years. (4) Be willing to agree to participate in this study and cooperate with the follow-up according to the requirements of this study.

Exclusion criteria

Exclusion criteria: (1) There are non-neoplastic serious diseases and dysfunction in major organs such as liver, kidney and heart. (2) Active cerebrovascular disease. (3) Uncontrolled infectious and metabolic diseases. (4) Pregnant women and mental patients.

Design outcomes

Primary

Measure	Time frame
Survival index, 5,10,15 year survival;Factors influencing patient survival rate and disease recurrence and metastasis rate (combined disease, KPS score);	—

Secondary

Measure	Time frame
Recurrence rate at 5,10,15 years;	—

Countries

China

Contacts

Public ContactXu Yun

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences

xyxiao78@163.com+86 15210775378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026